Status:

TERMINATED

Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

TriSalus Life Sciences, Inc.

Conditions:

Uterine Bleeding

Uterine Fibroid

Eligibility:

FEMALE

18-60 years

Phase:

NA

Brief Summary

The goal of this study is to assess of Pressure-Enabled Drug Delivery on fibroid treatment in patients undergoing UFE.

Detailed Description

Uterine fibroids are the most common tumor type in women of reproductive age and may be associated with abnormal menstrual bleeding, pain, sub-fertility, and diminished quality of life. For women inte...

Eligibility Criteria

Inclusion

  • Female, aged \>18 years.
  • Prior clinical decision for treatment by UFE.
  • One or more enhancing intramural, submucosal or subserosal fibroids on MRI.
  • Having either bulk symptoms or menorrhagia.

Exclusion

  • Absolute contraindication to contrast-enhanced MRI.
  • Current pregnancy.
  • Known history of adenomyosis.
  • Diagnosis of pelvic inflammatory disease.
  • Diagnosis of endometriosis.
  • Post-menopausal (no menses \>12-months).
  • Diagnosed gynecologic malignancy.
  • Prior uterine fibroid embolization treatment.
  • \>50% volume of non-enhancing fibroids.
  • Prior oophorectomy
  • GnRH agonist therapy within 6-months or GnRH antagonist therapy within 1-month prior to entering the study.
  • Target uterine vasculature not suitable for treatment with the TriNav Infusion System.
  • Allergy or intolerance to dilaudid.
  • Lack of ovarian perfusion on baseline MRI.

Key Trial Info

Start Date :

February 9 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 20 2025

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT06106633

Start Date

February 9 2023

End Date

January 20 2025

Last Update

April 24 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115